The point-of-care (POC) molecular diagnostics market is steadily expanding, with a compound annual growth rate (CAGR) of approximately 6%. This growth is fueled by a growing need for fast, ...

The global biochips market, valued at US$12.97 billion in 2024, stood at US$14.01 billion in 2025 and is projected to advance ...

The Global Cardiovascular Genetic Testing Market, valued at approximately USD 9.07 billion in 2023, is projected to grow at a robust compound annual growth rate (CAGR) of 11.2% du ...

To understand how microarray technology is evolving to meet growing scientific demands, Technology Networks spoke with Thermo ...

Pregnancy loss may occur in as many as 25% of all pregnancies. Most of these losses occur in the first trimester, and about ...

The Global MiRNA Microarray Kits And Reagents Market is projected to grow at a CAGR of 8.5% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals that ...

New studies reveal that optical genome mapping (OGM) can detect chromosomal abnormalities linked to recurrent pregnancy loss, ...

Pregnancy loss affects up to 25% of pregnancies. New studies using optical genome mapping reveal genetic and fragile-site ...

The data, which is being presented at this year's AMP meeting, offers some insights into the often hidden causes of recurrent pregnancy loss.

Pregnancy loss may occur in as many as 25% of all pregnancies. Most of these losses occur in the first trimester, and about half are caused by genetic or chromosomal issues.

Bionano Genomics, Inc. (NASDAQ: BNGO) Q3 2025 Earnings Call Transcript November 13, 2025 Bionano Genomics, Inc. beats earnings expectations. Reported EPS is $-1.59292, expectations were $-1.81.